← Open Payments lookup

KALEIGH WEEMS: Open Payments

NPI 1710605241 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,860 in 166 payments from 14 companies in 2025. Trend: 2023 $828 · 2024 $409 · 2025 $2,860

Food & beverage: $2,739Education: $121
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.23$495
E.R. Squibb & Sons, L.L.C.19$403
Teva Pharmaceuticals USA, Inc.16$317
Janssen Pharmaceuticals, Inc14$259
Alkermes, Inc.12$215
ABBVIE INC.19$206
Axsome Therapeutics, Inc.20$205
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$178
Takeda Pharmaceuticals U.S.A., Inc.13$167
Lundbeck LLC8$139

Products named: REXULTI, COBENFY, Auvelity, ARISTADA, VRAYLAR, CAPLYTA, TRINTELLIX, ABILIFY ASIMTUFII.

Industry payments across MO — which companies pay providers there.